The relationship of p53 and stress proteins in response to bleomycin and retinoic acid in the p53 heterozygous mouse.
A single, i.p. dose of bleomycin was administered simultaneously with [35S]methionine to 4-month-old p53 wild type (+/+) and p53 heterozygous (+/-) C57BL/6 mice. Following a period of 3.5 h from dosing, the bone marrow nuclei were examined by two-dimensional PAGE and fluorography for induction of stress proteins (sps). Eight sps ranging from 22000 to 100000 Mr were synthesized in p53+/- and p53+/+ mice following elicitation by bleomycin. No quantitative or qualitative differences were observed in sp expression in these two groups of animals. In a second experiment, three doses of retinoic acid were given i.p. to p53+/- and p53+/+ mice over a 36 h period. The p53 isoforms in bone marrow nuclei from these mice were analyzed by PAGE for incorporation of [35S]methionine following retinoic acid injections. Quantitative and qualitative alterations in p53 isotypes were substantially increased in p53+/+ as compared with p53+/- mice. The increased complexity in the synthesis patterns in both groups of dosed mice consisted of additional isoforms possessing more acidic isoelectric values. In an in vitro binding assay, individual p53 isoforms demonstrated varying degrees of association with sps 25a, 70i, 72c and 90 which was consistently greater in p53+/+ mice. Both the synthesis and binding of isoforms were greater in G1 than in S+G2 phase, in both groups of animals, reflecting a cell cycle regulated mechanism for these events. Collectively, these data implied that the synthesis and the binding characteristics of p53 isoforms with sps were enhanced in the p53+/+ mice relative to the p53+/- mouse; however, sp labeling was not affected by p53 genotype.
Pipkin
J L
JL
HFT-120, Division of Genetic and Reproductive Toxicology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA.
Hinson
W G
WG
James
S J
SJ
Shaddock
J G
JG
Lyn-Cook
L E
LE
Feuers
R J
RJ
Morris
S M
SM
Tolleson
W H
WH
Casciano
D A
DA
D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D015153:Blotting, Western; D001853:Bone Marrow / Q000378:metabolism; D002453:Cell Cycle; D002467:Cell Nucleus / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D015180:Electrophoresis, Gel, Two-Dimensional; D005456:Fluorescent Dyes; D006360:Heat-Shock Proteins / Q000096:biosynthesis / Q000378:metabolism*; D006579:Heterozygote; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010766:Phosphorylation; D020033:Protein Isoforms / Q000096:biosynthesis / Q000378:metabolism; D016622:Silver Staining; D013462:Sulfur Radioisotopes; D014212:Tretinoin / Q000494:pharmacology*; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*
D005456:Fluorescent Dyes; D006360:Heat-Shock Proteins; D020033:Protein Isoforms; D013462:Sulfur Radioisotopes; D016159:Tumor Suppressor Protein p53; D001761:Bleomycin; D014212:Tretinoin